CRISPR/Cas9 technology generated a C to G change resulting in a cysteine to tryptophan substitution at amino acid 130 (p.C130W). This corresponds to the human p.C134W variant seen in individuals with adult-type granulosa cell tumors. An additional mutation that destroys the Protospacer Adjacent Motif (GCC to GCA) was also introduced. (J:332589)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count